Ryan Specialty (NYSE:RYAN) Price Target Cut to $52.00 by Analysts at UBS Group

Posted by Brenda Bartman on Nov 2nd, 2026

Ryan Specialty (NYSE:RYAN – Get Free Report) had its price objective reduced by UBS Group from $55.00 to $52.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group‘s price objective points to a potential upside of 14.35% from the company’s current price.

RYAN has been the topic of several other reports. Morgan Stanley upped their price objective on shares of Ryan Specialty from $48.00 to $50.00 and gave the company an “overweight” rating in a report on Wednesday, August 19th. Piper Sandler lowered their target price on Ryan Specialty from $48.00 to $40.00 and set a “neutral” rating on the stock in a research note on Tuesday, October 6th. JPMorgan Chase & Co. lifted their price target on Ryan Specialty from $39.00 to $45.00 and gave the stock an “underweight” rating in a report on Monday, August 3rd. Cantor Fitzgerald boosted their price target on Ryan Specialty from $34.00 to $41.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Finally, Mizuho decreased their price objective on Ryan Specialty from $43.00 to $40.00 and set a “neutral” rating on the stock in a report on Wednesday, October 7th. Eight analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $52.15.

Check Out Our Latest Research Report on Ryan Specialty

Ryan Specialty Stock Up 3.7%

NYSE RYAN traded up $1.63 on Monday, reaching $45.47. The company had a trading volume of 2,434,540 shares, compared to its average volume of 2,200,786. The company’s fifty day moving average is $40.42 and its 200-day moving average is $39.17. The firm has a market capitalization of $11.63 billion, a price-to-earnings ratio of 56.14, a price-to-earnings-growth ratio of 0.90 and a beta of 0.54. The company has a debt-to-equity ratio of 4.03, a quick ratio of 1.00 and a current ratio of 1.01. Ryan Specialty has a 1-year low of $29.28 and a 1-year high of $58.94.

Ryan Specialty (NYSE:RYAN – Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.02. Ryan Specialty had a return on equity of 47.77% and a net margin of 8.25%. The company had revenue of $789.96 million during the quarter, compared to analysts’ expectations of $792.99 million. During the same period in the prior year, the firm earned $0.47 earnings per share. On average, research analysts forecast that Ryan Specialty will post 2.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of RYAN. Covestor Ltd boosted its position in shares of Ryan Specialty by 64.2% during the 3rd quarter. Covestor Ltd now owns 1,956 shares of the company’s stock worth $72,000 after acquiring an additional 765 shares in the last quarter. Integrity Alliance LLC. bought a new position in Ryan Specialty in the third quarter valued at approximately $1,040,000. Gerber Kawasaki Wealth & Investment Management acquired a new position in Ryan Specialty during the third quarter valued at approximately $854,000. Vise Technologies Inc. raised its position in Ryan Specialty by 189.0% during the third quarter. Vise Technologies Inc. now owns 24,941 shares of the company’s stock valued at $923,000 after purchasing an additional 16,311 shares in the last quarter. Finally, Motley Fool Asset Management LLC acquired a new position in Ryan Specialty during the third quarter valued at approximately $3,952,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.